dual AChE/MAO inhibitors (Hoechst Marion Roussel)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namedual AChE/MAO inhibitors (Hoechst Marion Roussel)
Drug Alias NameAlzheimers therapy (HMR)dual AChE/MAO inhibitors (HMR)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase inhibitorsAcetylcholinesterase inhibitors
TargetsMonoamine oxidaseAcetylcholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHoechst Marion Roussel Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHoechst Marion Roussel Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A